BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9951496)

  • 1. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.
    Katz J
    Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.
    Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL;
    Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mean deviation with AGIS and CIGTS scores in association with structural parameters in glaucomatous eyes.
    Naka M; Kanamori A; Tatsumi Y; Fujioka M; Nagai-Kusuhara A; Nakamura M; Negi A
    J Glaucoma; 2009; 18(5):379-84. PubMed ID: 19525728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of retinal nerve fiber layer measurement by StratusOCT and GDx VCC, II: structure/function regression analysis in glaucoma.
    Leung CK; Chong KK; Chan WM; Yiu CK; Tso MY; Woo J; Tsang MK; Tse KK; Yung WH
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3702-11. PubMed ID: 16186352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interocular asymmetry of visual field defects in primary open angle glaucoma and primary angle-closure glaucoma.
    Wang JC; Gazzard G; Foster PJ; Devereux JG; Oen FT; Chew PT; Khaw PT; Seah SK
    Eye (Lond); 2004 Apr; 18(4):365-8. PubMed ID: 15069431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of pascal dynamic contour tonometry and goldmann applanation tonometry in asymmetric open-angle glaucoma.
    Sullivan-Mee M; Halverson KD; Qualls C
    J Glaucoma; 2007 Dec; 16(8):694-9. PubMed ID: 18091457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual field progression in glaucoma: total versus pattern deviation analyses.
    Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical evaluation of the diagnostic accuracy of methods used to determine the progression of visual field defects in glaucoma.
    Mayama C; Araie M; Suzuki Y; Ishida K; Yamamoto T; Kitazawa Y; Shirakashi M; Abe H; Tsukamoto H; Mishima HK; Yoshimura K; Ohashi Y
    Ophthalmology; 2004 Nov; 111(11):2117-25. PubMed ID: 15522380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual field loss from primary angle-closure glaucoma: a comparative study of symptomatic and asymptomatic disease.
    Ang LP; Aung T; Chua WH; Yip LW; Chew PT
    Ophthalmology; 2004 Sep; 111(9):1636-40. PubMed ID: 15350315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of progressive change in automated visual fields in glaucoma.
    Smith SD; Katz J; Quigley HA
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1419-28. PubMed ID: 8641844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH; Hutchison DM; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mean deviation fluctuation in eyes with stable Humphrey 24-2 visual fields.
    Tattersall CL; Vernon SA; Menon GJ
    Eye (Lond); 2007 Mar; 21(3):362-6. PubMed ID: 16424913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A visual field index for calculation of glaucoma rate of progression.
    Bengtsson B; Heijl A
    Am J Ophthalmol; 2008 Feb; 145(2):343-53. PubMed ID: 18078852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.